Tip: Index histories & All-time highs

Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 17.04.2023       HAEMATO AG
GBC AG DE000A289VV1

Preliminary 2023 figures: Revenue and earnings development in line with expectations; Guidance issued against the backdrop of increased mandatory discounts; Target price: € 31.70; Rating: BUY   According to preliminary figures, HAEMATO AG had to accept a decline in turnover of 12.9% to € 248.2 million (previous year: € 285.0 mi [ … ]
Technical analysis
To the publication
Mon, 17.04.2023       Kleos Space S.A.
First Berlin Equity Research GmbH AU0000015588

First Berlin Equity Research has published a research update on Kleos Space S.A. (ISIN: AU0000015588). Analyst Christian Orquera reiterated his BUY rating and decreased the price target from AUD 1.00 to AUD 0.50. Abstract: Kleos Space SA (Kleos) has reported FY 2022 financial results which were overall slightly better than our estimates. Revenue [ … ]
To the publication
Mon, 17.04.2023       Kleos Space S.A.
First Berlin Equity Research GmbH AU0000015588

First Berlin Equity Research has published a research update on Kleos Space S.A. (ISIN: AU0000015588). Analyst Christian Orquera reiterated his BUY rating and decreased the price target from AUD 1.00 to AUD 0.50. Abstract: Kleos Space SA (Kleos) has reported FY 2022 financial results which were overall slightly better than our estimates. Revenue [ … ]
To the publication
Mon, 17.04.2023       First Tin Plc
GBC AG GB00BNR45554

Zwei neue Zinnminen mit geringem Investitionsaufwand in Deutschland und Australien.  ESG-konform. Hohes Upside-Potenzial. DFS-Studien bis Ende 2023 geplant. Investitionsentscheidungen bis Q1 2024.   Steigende Nachfrage nach Zinn. Zinn ist ein wichtiger Werkstoff, wenn es um die fortschreitende Elektrifizierung der Welt geht. Gleichzeitig [ … ]
Technical analysis
To the publication
Mon, 17.04.2023       First Tin Plc
GBC AG GB00BNR45554

Zwei neue Zinnminen mit geringem Investitionsaufwand in Deutschland und Australien.  ESG-konform. Hohes Upside-Potenzial. DFS-Studien bis Ende 2023 geplant. Investitionsentscheidungen bis Q1 2024.   Steigende Nachfrage nach Zinn. Zinn ist ein wichtiger Werkstoff, wenn es um die fortschreitende Elektrifizierung der Welt geht. Gleichzeitig [ … ]
Technical analysis
To the publication
Mon, 17.04.2023       PNE AG
First Berlin Equity Research GmbH DE000A0JBPG2

First Berlin Equity Research hat ein Research Update zu PNE AG (ISIN: DE000A0JBPG2) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 26,00 auf EUR 25,00. Zusammenfassung: PNE, seit Juni 2022 Mitglied im SDAX, hat für das Jahr 2022 endgültige Zahlen vorgelegt, die [ … ]
Technical analysis
To the publication
Mon, 17.04.2023       PNE AG
First Berlin Equity Research GmbH DE000A0JBPG2

First Berlin Equity Research hat ein Research Update zu PNE AG (ISIN: DE000A0JBPG2) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 26,00 auf EUR 25,00. Zusammenfassung: PNE, seit Juni 2022 Mitglied im SDAX, hat für das Jahr 2022 endgültige Zahlen vorgelegt, die [ … ]
Technical analysis
To the publication
Thu, 13.04.2023       Haemato AG
First Berlin Equity Research GmbH DE000A289VV1

First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 33,00. Zusammenfassung: Die vorläufigen Zahlen zeigten eine gute Rentabilität trotz des Wegfalls des Corona-Testgeschäfts, da [ … ]
Technical analysis
To the publication
Thu, 13.04.2023       Haemato AG
First Berlin Equity Research GmbH DE000A289VV1

First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 33,00. Zusammenfassung: Die vorläufigen Zahlen zeigten eine gute Rentabilität trotz des Wegfalls des Corona-Testgeschäfts, da [ … ]
Technical analysis
To the publication
Tue, 11.04.2023       Cardiol Therapeutics Inc
First Berlin Equity Research GmbH CA14161Y2006

First Berlin Equity Research hat die Coverage von Cardiol Therapeutics Inc (ISIN: CA14161Y2006) aufgenommen. Das Rating von Analyst Christian Orquera ist BUY bei einem Kursziel von USD 3,60 (€3,30). Zusammenfassung: Cardiol Therapeutics Inc. (Cardiol) ist ein Biotech-Unternehmen mit einer Produktpipeline im klinischen Stadium, die sich auf  [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 13.05.2025, Calendar Week 20, 133rd day of the year, 232 days remaining until EoY.